Characteristics | Amivantamab (N = 798) |
---|---|
Sex | |
Female | 367 (46.0%) |
Male | 225 (28.2%) |
Missing | 206 (25.8%) |
Weight | |
<50 kg | 48 (6.0%) |
>100 kg | 6 (0.8%) |
50–100 kg | 268 (33.6%) |
Missing | 476 (59.6%) |
Age | |
>85 year | 3 (0.4%) |
18–65 year | 215 (26.9%) |
65–85 year | 212 (26.6%) |
Missing | 368 (46.1%) |
Occupations | |
Consumers | 69 (8.6%) |
Profession-healther | 728 (91.3%) |
Missing | 1 (0.1%) |
Country | |
US | 386 (48.4%) |
China | 77 (9.6%) |
France | 31 (3.9%) |
Japan | 25 (3.1%) |
South Korea | 23 (2.9%) |
Others | 256 (32%) |